Funding Available in Cancer Research and Technology for Innovative Small Businesses

Is your small business in need of financing to support the development of its innovative cancer research? Don’t miss out on two special funding opportunities from The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center: The FY2015 Contract Topics and the SBIR Innovative Molecular Analysis Technology (IMAT) Development for Cancer Research and Clinical Care.

Applications for both of these funding opportunities are due in early November. Review the opportunities below and apply today!

Additionally, the NIH has just announced the launch of the Niche Assessment Program for all active NIH SBIR/STTR Phase I awardees (by grant or contract). Additional details on the program are below.

NCI SBIR Contract Topics Funding Opportunities
Due date: November 5, 2014 by 4:30 p.m. ET

The PHS 2015-1 solicitation includes the following contract topics for qualified small businesses to help advance the research, development, and commercialization of cancer research and technology in priority areas:

Learn more about the difference between SBIR contracts and grants. View the presentation slides from the latest webinar on Contract Topics.

If you have questions about any of the topics or general questions on contract administration, please contact:

Ms. Victoria Cunningham
E-mail: ncioasbir@mail.nih.gov

Please include Solicitation PHS 2015-1 and the Topic Number when submitting questions.

NCI SBIR Funding Opportunity: Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care
Next due date: November 4, 2014

The SBIR-IMAT solicitation is a companion announcement to the NCI Innovative Molecular Analysis Technologies (IMAT) Program aimed at the inception, development, integration, and application of novel and emerging technologies in support of cancer research.
This solicitation will provide small businesses the opportunity to advance technologies that improve molecular and/or cellular analysis of cancer with a significant likelihood for either overcoming persistent challenges or obstacles or opening entirely new fields for cancer research or clinical care. View the presentation slides from the latest webinar on SBIR-IMAT.

To view the full SBIR-IMAT FOA, please visit:
PAR-13-327, Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44)

For more information or questions on the SBIR-IMAT funding opportunity, please contact:

Amir Rahbar, PhD, MBA
Program Director, NCI SBIR
Email: rahbaram@mail.nih.gov

 

Announcements from NIH: Resources for Small Business Applicants

NIH recently announced the Niche Assessment Program, which provides SBIR and STTR Phase I awardees with a free comprehensive market analysis report that can help jump start commercialization efforts for small businesses. Applications are accepted on a first-come, first served basis until all 136 slots are filled. Learn more and apply!

Advertisements

Tags:

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: